MD Anderson Orlando

Orlando, Florida 32806

0 studies enrolling now · 3 studies all time

What they study most

Multiple Myeloma, Non-Small Cell Lung Cancer, Peripheral T-cell Lymphoma

Studies at this site

• A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma — Stopped early
• Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry — Completed
• Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer — Stopped early